In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report), with a price target of $9.00. The company’s shares opened today at $3.62.
According to TipRanks, Chen is an analyst with an average return of -28.7% and a 26.33% success rate. Chen covers the Healthcare sector, focusing on stocks such as Veru, Kala Pharmaceuticals, and Aslan Pharmaceuticals.
Currently, the analyst consensus on Alpha Tau Medical Ltd is a Strong Buy with an average price target of $11.33, a 212.98% upside from current levels. In a report released today, Piper Sandler also reiterated a Buy rating on the stock with a $12.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
DRTS market cap is currently $275.7M and has a P/E ratio of -15.80.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Healthcare Capital Corp is a blank check company.
Read More on DRTS:
- Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update
- DRTS Earnings this Week: How Will it Perform?
- Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
- Alpha Tau initiated with a Buy at H.C. Wainwright
- Alpha Tau, JGH announce Alpha DaRT treatment of first patient
